post #301 of 314
9/25/09 at 2:34am
stock came back to life. anyone know the status or results from investigation?
lol so your saying you got a bunch of junk stocks in your account accumulated over the past 15yrs lol
Well I hope that it 'pumps' back up. I am sitting on 2000 shares I bought at 1.05!! Ouch. They at least appear to have a seasoned CEO at the helm...
> GENova Biotherapeutics, Inc., (“GENova”), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief
Mr. Whiteman, is a graduate of Oxford University and London School of Economics. He will provide GENova with his unique blend
of exceptional sales, marketing, business and networking skills, combined with solid business management experience and the vision
to marry novel products with new market opportunities. Mr. Whiteman has extensive experience in team building and negotiation. He
has previously worked with companies such as Reliance Biotech and Viranative, closing license deals with big pharma companies
such as Astra Zeneca, Pharmacia and GSKB.
Mr. Whiteman said, "I am excited to provide the executive leadership to take GENova to its next stage of growth in this crucial phase
of commercializing GENova’s technology in the marketplace."